HighTower Advisors
STAA icon

HighTower Advisors’s STAAR Surgical STAA Stock Holding History

HighTower Advisors’s Portfolio STAA Stock Details STAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,956
Closed -$315K – 4031
2024
Q4 		$315K Buy
12,956
+3,871
+43% +$111K ﹤0.01% 2857
2024
Q3 		$336K Buy
+9,085
New +$339K ﹤0.01% 2740

Other funds holding STAA

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
RAM
Resona Asset Management Koto-Ku,tokyo, Japan $20.1B AUM 26.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
YC
Yunqi Capital Hong Kong $92.4M AUM 16.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return

HighTower Advisors's STAA Position: Q1 2025 in Review

HighTower Advisors sold out of STAAR Surgical (STAA) in Q1 2025, closing a stake of 12,956 shares — an estimated $315K sold.

HighTower Advisors first reported a position in STAA in Q3 2024 and held it in 2 quarters. The position peaked at $336K in Q3 2024. 185 funds tracked by Wall St. Rank hold STAA as of Q1 2025.

  • HighTower Advisors reported no remaining STAAR Surgical position as of Q1 2025 after selling out during the quarter.
  • HighTower Advisors sold 12,956 STAAR Surgical shares in Q1 2025, an estimated $315K.
  • HighTower Advisors first reported a position in STAAR Surgical in Q3 2024 and held it in 2 quarters.
  • HighTower Advisors's STAAR Surgical position peaked at $336K in Q3 2024.
  • 185 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2025.

Based on HighTower Advisors's 13F filing for Q1 2025, filed 13 May 2025.